Submit a comment
Citation Information: J Clin Invest. 1972;51(4):955-963. https://doi.org/10.1172/JCI106890.
Abstract
Human sera have been examined for antibodies with specific reactivity for γE using the tanned cell hemagglutination test. Cells tanned with three different γE myeloma proteins provided a reproducible test system. Inhibition of agglutination reactions by γE proteins, but not by γG, γA, γM, or γD confirmed the specificity of these reactions. 8.5% of 304 serial serum samples obtained from miscellaneous hospitalized patients showed clear-cut anti-γ-globulins with specificity for γE. In most of these instances no definite clinical history of concomitant allergic disorders could be obtained. 53% of 73 patients with well-established allergic disorders (hay fever, extrinsic asthma) showed serum anti-γ-globulins with reactivity for γE. Some patients studied before and after desensitization to Bermuda grass allergen showed an increase in titer or a conversion from negative to positive reactions for anti-γE antibodies following several month courses of progressive desensitization. Gradient and gel filtration studies indicated that anti-γE globulins were 19S γM in all instances. No clear correlation was noted between quantitative serum γE levels and titer of anti-γE antibodies.
Authors
Ralph C. Williams Jr., Robert W. Griffiths, Jean D. Emmons, Richard C. Field
Guidelines
The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.
- Comments appear on the Journal’s website and are linked from the original article’s web page.
- Authors are notified by email if their comments are posted.
- The Journal reserves the right to edit comments for length and clarity.
- No appeals will be considered.
- Comments are not indexed in PubMed.
Specific requirements
- Maximum length, 400 words
- Entered as plain text or HTML
- Author’s name and email address, to be posted with the comment
- Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
- Comments may not include figures
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)